Best Possible Treatment for All Patients with Primary Immune Deficiency (PID) in Sweden Regardless of Social Factors, Sex, Age or Residence - 19/04/17
Doi : 10.1016/j.jaci.2016.12.800
Janne F. Bjorkander, PhD 1, Nicholas Brodszki, MD, PhD 2, Åsa Carlsson, MD 3, Anders Fasth, MD, PhD 4, Susanne Hansen 5, Ann-Sofie Isaksson-Nordmark 6, Susanne Larsson 7, Åsa Nilsdotter, MD 8, Mats Nilsson, MD, PhD 1, Lena Nordfält 9, Sólveig Oskarsdóttir, MD, PD 4, Annika Wallin, MD 10, Per Wågström, MD 11
1 Futurum-Academy of Health and Care, Jonkoping, Sweden
2 Childrens Hospital, Lund University Hospital, Lund, Sweden
3 Dept of Infectious Diseases, Lulea, Sweden
4 Dept of Pediatrics, Goteborg, Sweden
5 Dept of Infectious Diseases, Stockholm, Sweden
6 Swedish Patient Organization (PIO), Boden, Sweden
7 Swedish Patient Organization (PIO), Kalix, Sweden
8 Dept of Infectious Diseases, Linkoping, Sweden
9 Dept of Internal Medicine, Ostersund, Sweden
10 Dept of Internal Medicine, Umea, Sweden
11 Dept of Infectious Diseases, Jonkoping, Sweden
780
Le texte complet de cet article est disponible en PDF.Plan
© 2016
Publié par Elsevier Masson SAS.
Vol 139 - N° 2S
P. AB249 - février 2017 Retour au numéro
Article précédent
- Persistent Diffuse Skin Eruption and Tingling in the Extremities of Unknown Etiology Diagnosed As Mercury Poisining and and Vit B-6 Toxicity
- Richard M. Harris
- Preferences in social media in patients with obstructive lung disease
- Jose M. Vilema, Juan C. Calderon, Annia J. Cherrez Chica, German D. Ramon, Blanca M. Morfin-Maciel, Alan P. Baptist, Orlando Lopez-Jove, Erick Calero, Jose Cano, Karin Plaza, Ivan Cherrez Ojeda
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?